Caveolin-1--a novel interacting partner of organic cation/carnitine transporter (Octn2): effect of protein kinase C on this interaction in rat astrocytes

PLoS One. 2013 Dec 13;8(12):e82105. doi: 10.1371/journal.pone.0082105. eCollection 2013.

Abstract

OCTN2--the Organic Cation Transporter Novel family member 2 (SLC22A5) is known to be a xenobiotic/drug transporter. It transports as well carnitine--a compound necessary for oxidation of fatty acids and mutations of its gene cause primary carnitine deficiency. Octn2 regulation by protein kinase C (PKC) was studied in rat astrocytes--cells in which β-oxidation takes place in the brain. Activation of PKC with phorbol ester stimulated L-carnitine transport and increased cell surface presence of the transporter, although no PKC-specific phosphorylation of Octn2 could be detected. PKC activation resulted in an augmented Octn2 presence in cholesterol/sphingolipid-rich microdomains of plasma membrane (rafts) and increased co-precipitation of Octn2 with raft-proteins, caveolin-1 and flotillin-1. Deletion of potential caveolin-1 binding motifs pointed to amino acids 14-22 and 447-454 as the caveolin-1 binding sites within Octn2 sequence. A direct interaction of Octn2 with caveolin-1 in astrocytes upon PKC activation was detected by proximity ligation assay, while such an interaction was excluded in case of flotillin-1. Functioning of a multi-protein complex regulated by PKC has been postulated in rOctn2 trafficking to the cell surface, a process which could be important both under physiological conditions, when carnitine facilitates fatty acids catabolism and controls free Coenzyme A pool as well as in pathology, when transport of several drugs can induce secondary carnitine deficiency.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Astrocytes / drug effects
  • Astrocytes / enzymology*
  • Astrocytes / metabolism
  • Astrocytes / ultrastructure
  • Biological Transport / drug effects
  • Carnitine / metabolism
  • Caveolin 1 / chemistry
  • Caveolin 1 / metabolism*
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism
  • Enzyme Activation / drug effects
  • HEK293 Cells
  • Humans
  • Immunoprecipitation
  • Membrane Microdomains / metabolism
  • Membrane Proteins / metabolism
  • Organic Cation Transport Proteins / metabolism*
  • Phosphorylation / drug effects
  • Protein Binding / drug effects
  • Protein Kinase C / metabolism*
  • Protein Structure, Tertiary
  • Rats
  • Reproducibility of Results
  • Solute Carrier Family 22 Member 5
  • Tetradecanoylphorbol Acetate / pharmacology

Substances

  • Caveolin 1
  • Membrane Proteins
  • Organic Cation Transport Proteins
  • Slc22a5 protein, rat
  • Solute Carrier Family 22 Member 5
  • flotillins
  • Protein Kinase C
  • Tetradecanoylphorbol Acetate
  • Carnitine

Grants and funding

This work was financed by grant 4427/B/P01/2010/38 from the Polish Ministry of Science and Higher Education/National Science Centre (http://www.ncn.gov.pl) and by the Nencki Institute (http://www.nencki.gov.pl). KM receives a scholarship funded by the “International PhD Studies in Neurobiology” - project MPD/2009/4 of the Foundation for Polish Science (http://www.fnp.org.pl), co-financed by the European Union Innovative Economy Operational Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.